The Health Impact of MAFLD, a Novel Disease Cluster of NAFLD, Is Amplified by the
      Integrated Effect of Fatty Liver Disease–Related Genetic Variants

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

<p class="first" id="d8804976e158">Metabolic dysfunction-associated fatty liver disease (MAFLD) is a newly proposed disease category that derived from non-alcoholic fatty liver disease. The impact of MAFLD on health events has not been investigated. </p>

Related collections

Author and article information

Contributors

Xingdong Chen: (View ORCID Profile)

Journal

Title: Clinical Gastroenterology and Hepatology

Abbreviated Title: Clinical Gastroenterology and Hepatology

Publisher: Elsevier BV

ISSN (Print): 15423565

Publication date Created: December 2020

Publication date (Print): December 2020

Article

DOI: 10.1016/j.cgh.2020.12.033

PubMed ID: 33387670

SO-VID: 8f0cc9fb-28a8-4f08-aecf-b8968976b723

License:

https://www.elsevier.com/tdm/userlicense/1.0/

History

Data availability:

Comments

Comment on this article

scite_

0

Smart Citations

0

Citing PublicationsSupportingMentioningContrasting

View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.